Credit: Getty Images. Medications for ulcerative colitis include first-line therapy 5-ASA for mild cases as well as immune system–altering biologics for more severe cases. The initial treatment with ...

Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory Ulcerative ...

French biotech company Abivax said new clinical trial data supports the safety and effectiveness of its experimental ...

U.S.-listed shares of Abivax climbed more than 25% in after-hours trading after the French biotech released new data aimed at ...

Tremfya is a brand-name medication used to treat moderate to severe ulcerative colitis in adults by targeting a protein that reduces inflammation in the large intestine. Treatment with Tremfya ...

An experimental monoclonal antibody treatment appears to ease the digestive disorder ulcerative colitis in patients who've failed other medications, a new trial shows. The treatment, tulisokibart, ...

What Does Treatment Failure Mean if You Have Ulcerative Colitis? Alan Moss, MD, chief scientific officer of the Crohns & Colitis Foundation, defines what constitutes ulcerative colitis treatment ...

Share on Pinterest New research is testing the medication tulisokibart in treating ulcerative colitis. Maria Korneeva/Getty Images Ulcerative colitis is a type of inflammatory bowel disease (IBD) and ...

Nearly 70 percent of adolescents and young adults with ulcerative colitis stop taking medication to treat the disease within a year of diagnosis. Ulcerative colitis is an inflammatory bowel disease ...

You and your doctor already have a variety of treatment options available for ulcerative colitis (UC), but science marches on, with the pharmaceutical industry close behind. Dozens of novel therapies ...

AbivaxABVX stock crashed by more than a third Tuesday despite what one analyst called "best-case" results for a study of its ulcerative colitis treatment after several patients developed cancer. At ...